Anglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long-acting antibody combination (LAAB) for the potential prevention and treatment of Covid-19, pharma company's India managing director Gagandeep
from Industry-Economic Times
Read The Rest:economictimes...